Evidence still lacking that vitamins prevent CVD, cancer: USPSTFJune 24, 2022Preventive CareMixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Patients with blood cancers underutilize palliative careJune 23, 2022Patient & Survivor CareASCO Lung CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPractice Management
Improved cancer survival in states with ACA Medicaid expansionMay 19, 2022Practice ManagementGastrointestinal CancerLung CancerLymphoma & Plasma Cell Disorders
Dodging potholes from cancer care to hospice transitionsMay 6, 2022Patient & Survivor CareBreast CancerCNS/Brain CancerFollicular LymphomaGastrointestinal CancerGenitourinary CancerGynecologic Cancer
Few new cancer drugs replace current standards of careMarch 24, 2022Mixed TopicsGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Ways to lessen toxic effects of chemo in older adultsMarch 17, 2022Patient & Survivor CareCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
Filling opioid prescriptions akin to a Sisyphean taskMarch 8, 2022Opioid Resource CenterGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung CancerMetastatic Breast Cancer
Rituximab and COVID-19 vaccines: Studies begin to answer key questionsJanuary 21, 2022COVID-19 UpdatesLymphoma & Plasma Cell DisordersDLBCL
Convenience, not outcomes may drive robot-assisted surgeriesOctober 25, 2021Gastrointestinal CancerBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
Many patients, doctors unaware of advancements in cancer careOctober 4, 2021Mixed TopicsBreast CancerCNS/Brain CancerFollicular LymphomaGastrointestinal CancerGenitourinary CancerGynecologic Cancer
Most community-based oncologists skip biomarker testingSeptember 21, 2021Lung CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
FDA grants zanubrutinib an accelerated approval in marginal zone lymphomaSeptember 16, 2021Lymphoma & Plasma Cell Disorders
Can reversing T-cell exhaustion benefit in B-cell lymphoma relapse?September 15, 2021Lymphoma & Plasma Cell Disorders
FDA approves zanubrutinib in Waldenström’s macroglobulinemiaSeptember 7, 2021Lymphoma & Plasma Cell Disorders
